Alcon agreed to buy LENSAR for $14.00/share cash, integrating ALLY, Streamline, and the legacy laser system to expand FLACS ...
When text on street signs starts to blur or night driving feels harder than it used to, choosing a certified ophthalmologist in Cape Coral becomes less of ...
One medtech analyst raises concerns that Lensar's acquisition by Alcon is in trouble due to the company's recent priority ...
US News evaluated freestanding ASCs only, excluding hospital-affiliated outpatient departments to avoid overlap with hospital rankings and maintain comparability across facility types. Methodology ...
Alcon and Lensar terminate merger due to FTC challenges. Lensar retains a $10M deposit and focuses on Ally laser growth. More updates on March 31.
Retained lens fragments are a frustrating complication that can challenge even the most meticulous cataract surgeon.While modern phacoemulsification has made the procedure remarkably efficient, the ...
Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that three scientific abstracts highlighting its commercial products VEVYE® ...
I testified on three Bills at the Colorado Assembly on March 9, 2026. For the third time in a decade, Legislative Democrats blocked a bill requiring safety regulations and inspections for second ...
Most health insurance plans in India don’t automatically cover LASIK, but exceptions exist. Here’s how medical necessity, limits and waiting periods determine your eligibility.
As Spring approaches and your thoughts begin to turn to those outdoor pleasures, it may be the right time to put your wellbeing first and get it sorted! For more information about Wellsoon private ...
Harrow, Inc. is rapidly evolving into a dominant US ophthalmic pharma player, with a 30-fold revenue increase since 2015 and ...
The medical landscape undergoes a rapid transformation as precision becomes the standard of care. At the heart of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results